Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Croda International ( (GB:CRDA) ).
Croda International has granted conditional awards of ordinary shares under its Performance Share Plan 2014 and Deferred Bonus Share Plan to a group of senior executives and committee members, including executive directors and members of the executive and finance committees. The nil-cost awards, dated 19 March 2026, form part of the company’s long-term incentive and deferred bonus arrangements, aligning management compensation more closely with shareholder interests through equity-based remuneration.
The grants cover varying volumes of performance and deferred bonus share awards for nine individuals, reflecting their respective roles and responsibilities within the group’s leadership structure. By continuing to use share-based incentives rather than cash, Croda reinforces a pay-for-performance culture intended to support retention of key personnel and drive long-term value creation, which may be viewed positively by investors monitoring governance and executive remuneration practices.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £2770.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Spark’s Take on CRDA Stock
According to Spark, TipRanks’ AI Analyst, CRDA is a Neutral.
The score reflects solid financial stability (manageable leverage and positive cash generation) and supportive technical momentum, balanced against a demanding valuation (high P/E) and execution risk highlighted on the earnings call (exceptional charges and segment volatility despite improving guidance and transformation progress).
To see Spark’s full report on CRDA stock, click here.
More about Croda International
Croda International is a UK-based specialty chemicals company that develops and manufactures high-performance ingredients and technologies for sectors including personal care, life sciences and industrial markets. The group focuses on innovative, sustainable formulations used by global consumer and industrial brands, positioning it as a key supplier in value-added chemical solutions.
Average Trading Volume: 557,990
Technical Sentiment Signal: Strong Sell
Current Market Cap: £3.51B
For an in-depth examination of CRDA stock, go to TipRanks’ Overview page.